相似文献
1
Strongyloidiasis in immunocompromised migrants to non-endemic countries in the era of COVID-19: what is the role for presumptive ivermectin?
J Travel Med. 2022 Jan 17;29(1). doi: 10.1093/jtm/taab155.
2
Strongyloidiasis Hyperinfection Syndrome in COVID-19 Positive Migrants Treated with Corticosteroids.
J Immigr Minor Health. 2022 Dec;24(6):1431-1434. doi: 10.1007/s10903-022-01386-w. Epub 2022 Aug 8.
3
Strongyloidiasis in Auckland: A ten-year retrospective study of diagnosis, treatment and outcomes of a predominantly Polynesian and Fijian migrant cohort.
PLoS Negl Trop Dis. 2024 Mar 28;18(3):e0012045. doi: 10.1371/journal.pntd.0012045. eCollection 2024 Mar.
4
Disseminated Strongyloides stercoralis infection with a cutaneous presentation in an immunosuppressed patient.
Eur J Dermatol. 2009 Jul-Aug;19(4):404-5. doi: 10.1684/ejd.2009.0701. Epub 2009 May 25.
5
Influence of the drugs used in migrant patients with severe acute respiratory syndrome coronavirus 2 and the development of symptomatic strongyloidiasis.
Trans R Soc Trop Med Hyg. 2022 May 2;116(5):440-445. doi: 10.1093/trstmh/trab152.
6
Dexamethasone and COVID-19: Strategies in Low- and Middle-Income Countries to Tackle Steroid-Related Strongyloides Hyperinfection.
Am J Trop Med Hyg. 2021 Mar 15;104(5):1611-1612. doi: 10.4269/ajtmh.20-1085.
7
Strongyloides hyperinfection: a treatment dilemma.
Am J Med Sci. 2008 Oct;336(4):358-61. doi: 10.1097/MAJ.0b013e31815cff89.
8
Case of Strongyloides hyperinfection syndrome.
BMJ Case Rep. 2017 Feb 8;2017:bcr2016218320. doi: 10.1136/bcr-2016-218320.
9
Late post-kidney transplant Strongyloides hyperinfection syndrome.
Transpl Infect Dis. 2018 Dec;20(6):e12975. doi: 10.1111/tid.12975. Epub 2018 Sep 3.
10
Subcutaneous ivermectin for the treatment of the hyperinfection syndrome by Strongyloides stercoralis.
Biomedica. 2020 Jun 15;40(2):228-232. doi: 10.7705/biomedica.5140.
引用本文的文献
1
Infectious Disease Prophylaxis During and After Immunosuppressive Therapy.
Kidney Int Rep. 2024 Apr 25;9(8):2337-2352. doi: 10.1016/j.ekir.2024.04.043. eCollection 2024 Aug.
2
Strongyloides stercoralis Infection in Humans: A Narrative Review of the Most Neglected Parasitic Disease.
Cureus. 2023 Oct 12;15(10):e46908. doi: 10.7759/cureus.46908. eCollection 2023 Oct.
3
Off-label drug use during the COVID-19 pandemic in Africa: topic modelling and sentiment analysis of ivermectin in South Africa and Nigeria as a case study.
J R Soc Interface. 2023 Sep;20(206):20230200. doi: 10.1098/rsif.2023.0200. Epub 2023 Sep 13.
4
Strongyloides and COVID-19: Challenges and Opportunities for Future Research.
Trop Med Infect Dis. 2023 Feb 19;8(2):127. doi: 10.3390/tropicalmed8020127.
5
Evaluation of Strongyloides Awareness and Knowledge among Canadian Physicians Caring for Patients At Risk for Severe Strongyloidiasis: A National Cross-sectional Survey.
Am J Trop Med Hyg. 2022 Jul 5;107(2):359-366. doi: 10.4269/ajtmh.22-0109. Print 2022 Aug 17.
6
A Practical Approach to Screening for .
Trop Med Infect Dis. 2021 Nov 29;6(4):203. doi: 10.3390/tropicalmed6040203.
Zotero 插件